Diagnosis & Disease Information

SBRT Does Not Improve Efficacy of Nivo-Ipi in Advanced Merkel Cell Carcinoma

By

Leah Lawrence

September 27, 2022

SBRT did not improve the efficacy of nivolumab-ipilimumab in patients with advanced Merkel cell carcinoma in a phase 2 study.

Merkel cell carcinoma

Merkel Cell Carcinoma Stage Is Strong Predictor of Recurrence Risk

By

Colby Stong

March 30, 2022

Risk of stage-specific Merkel cell carcinoma (MCC) recurrence and mortality over time since diagnosis is estimated.

Next post in Skin Cancer

Relatlimab-Nivolumab Prolongs PFS in Metastatic Melanoma